Rajeev Shah

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -34% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Satsuma Pharmaceuticals Inc None -
Director Kalvista Pharmaceuticals Inc Nov. 21, 2016 - April 16, 2018
Rajeev Shah's trades of KALA BIO Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-03-13 2020-03-13
US KALA BIO Inc (KALA)
B Purchase
43,221 -0.5%
138.69
US$1,867,881 		43,221 -0.5% 138.69 US$1,867,881
2020-02-05 2020-02-03
B Purchase
20,759 +40.5%
412.91
US$743,693 		20,759 +40.5% 412.91 US$743,693
2020-02-05 2020-02-03
B Purchase
19,262 -3.7%
348.50
US$3,771,944 		19,262 -3.7% 348.50 US$3,771,944
2020-02-05 2020-02-03
B Purchase
785,658 +69.0%
19.00
US$14,927,502 		785,658 +69.0% 19.00 US$14,927,502
2019-09-17 2019-09-17
B Purchase
192,387 +4.3%
15.00
US$2,885,805 		192,387 +4.3% 15.00 US$2,885,805
2019-09-17 2019-09-17
B Purchase
1,140,946 +34.1%
15.00
US$17,114,190 		1,140,946 +34.1% 15.00 US$17,114,190